A secret that hides Akebia Therapeutics Inc.’s strength (NASDAQ:AKBA)

Stocks of Akebia Therapeutics Inc. (NASDAQ:AKBA) traded higher last session on Wall Street, up 6.37% to $2.17. AKBA stock price is now 38.57% away from the 50-day moving average and 72.17% away from the 200-day moving average. The market capitalization of the company currently stands at $454.33M. On August 28, 2023, H.C. Wainwright Upgraded its […]

Does Akebia Therapeutics Inc. (NASDAQ:AKBA) have deteriorating prospects?

Akebia Therapeutics Inc. (NASDAQ:AKBA) shares traded 24.09% higher at $1.70 on Wall Street last session. AKBA stock price is now 11.26% away from the 50-day moving average and 37.11% away from the 200-day moving average. The market capitalization of the company currently stands at $320.26M. On August 28, 2023, H.C. Wainwright Upgraded its previous ‘Neutral’ […]

How should investors evaluate Akebia Therapeutics Inc. (NASDAQ:AKBA)?

Stocks of Akebia Therapeutics Inc. (NASDAQ:AKBA) traded higher last session on Wall Street, down -1.36% to $1.45. According to the data, Akebia Therapeutics Inc. (NASDAQ:AKBA) has 2 analysts covering its stock. The consensus rating among analysts is ‘Overweight’. As we calculate the median target price by taking the range between a high of $4.00 and […]

Akebia Therapeutics Inc. (AKBA) Holding Strong: What’s pushing it?

In yesterday’s Wall Street session, Akebia Therapeutics Inc. (NASDAQ:AKBA) shares traded at $0.87, down -3.25% from the previous session. 2 analysts cover Akebia Therapeutics Inc. (NASDAQ:AKBA), according to research data. The consensus rating among analysts is ‘Overweight’. As we calculate the median target price by taking the range between a high of $4.00 and a […]